Recent Highlights in the Development of Isatin-Based Anticancer Agents
Kara L. Vine(University of Wollongong), Danielle Skropeta(University of Wollongong), Julie M. Locke, Lidia Matesic
Cited by 69
Related Papers
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
|Journal of Controlled Release|2018|297
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
|Anti-Cancer Agents in Medicinal Chemistry|2009|269
Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook
|Advanced Materials|2018|217
In vitro cytotoxicity evaluation of some substituted isatin derivatives
|Bioorganic & Medicinal Chemistry|2006|193
An Investigation into the Cytotoxicity and Mode of Action of Some Novel <i>N</i>-Alkyl-Substituted Isatins
|Journal of Medicinal Chemistry|2007|150